Effectiveness of Lumefantrine-Artemether for Malaria Treatment in Zambia
Author Information
Author(s): Mulenga Modest, Van geertruyden Jean-Pierre, Mwananyanda Lawrence, Chalwe Victor, Moerman Filip, Chilengi Roma, Van Overmeir Chantal, Dujardin Jean-Claude, D'Alessandro Umberto
Primary Institution: Institute of Tropical Medicine, Antwerp, Belgium
Hypothesis
Is lumefantrine-artemether more effective than sulfadoxine-pyrimethamine for treating uncomplicated malaria in Zambian adults?
Conclusion
Lumefantrine-artemether is significantly more effective than sulfadoxine-pyrimethamine for treating uncomplicated malaria in Zambian adults.
Supporting Evidence
- Fever at day 3 was significantly lower in the AL group compared to SP.
- Mean hemoglobin at day 45 was significantly higher in the AL group.
- Early treatment failure was significantly higher in the SP group.
- Total treatment failure was significantly higher in the SP group.
Takeaway
This study shows that a new malaria treatment works much better than the old one for adults in Zambia.
Methodology
971 adult patients were randomized to receive either sulfadoxine-pyrimethamine or lumefantrine-artemether and followed for 45 days.
Potential Biases
Potential bias due to non-supervised treatment and patient compliance issues.
Limitations
The study did not include pregnant women and was conducted in a specific geographic area.
Participant Demographics
Adults aged 15-50 years, with a similar distribution of gender and clinical characteristics across treatment groups.
Statistical Information
P-Value
0.007
Confidence Interval
95% CI: 3.08–55.50
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website